Genpact CEO awarded 106,575 restricted share units

Genpact Limited’s President and CEO, Balkrishan Kalra, reported an equity compensation grant in the form of restricted share units.

Rhea-AI Filing Summary

Genpact Limited’s President and CEO, Balkrishan Kalra, reported an equity compensation grant in the form of restricted share units. On January 30, 2026, he was awarded 106,575 common shares at a price of $0 per share, increasing his beneficial ownership to 497,260 common shares, held directly.

The award represents unvested restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share upon vesting. One-third of the shares will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, contingent on his continued service through each vesting date.

Insider Trade Summary

Grant/Award: 106,575 shares

Grant/Award 1 txn

Insider Kalra Balkrishan

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	106,575	$0.00	$0.00

Holdings After Transaction: Common Shares — 497,260 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

FAQ

What insider transaction did Genpact (G) report for its CEO?

Genpact (G) reported that President and CEO Balkrishan Kalra received an equity award of 106,575 common shares at a price of $0 per share. These represent restricted share units that will convert into common shares as they vest over future dates.

How many Genpact (G) shares does the CEO own after this Form 4 transaction?

After the reported transaction, Genpact (G) President and CEO Balkrishan Kalra beneficially owns 497,260 common shares directly. This total includes the newly awarded 106,575 restricted share units reported as acquired on January 30, 2026, at a price of $0 per share.

What type of equity did Genpact (G) grant its CEO in this filing?

Genpact (G) granted President and CEO Balkrishan Kalra unvested restricted share units (RSUs) under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles him to receive one Genpact Limited common share when it vests, subject to continued service conditions.

What is the vesting schedule for the CEO’s RSU award at Genpact (G)?

The RSU award vests in three equal installments. One-third of the shares vests on January 10, 2027, another third on January 10, 2028, and the final third on January 10, 2029. Vesting requires Balkrishan Kalra’s continued service through each vesting date.

Was cash paid for the CEO’s Genpact (G) share award reported on Form 4?

No cash was paid for the CEO’s reported share award. The Form 4 shows 106,575 Genpact common shares acquired at a price of $0 per share, reflecting an equity compensation grant rather than an open-market purchase or sale transaction.

Under which plan were the CEO’s RSUs granted at Genpact (G)?

The restricted share units granted to Genpact (G) President and CEO Balkrishan Kalra were issued under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. This plan governs equity incentive awards such as RSUs that convert into common shares upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalra Balkrishan

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/30/2026		A		106,575(1)	A	$0	497,260	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.